CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
St. Jude Children's Research Hospital
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Gilead Sciences
Center for International Blood and Marrow Transplant Research
Allogene Therapeutics
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
Baptist Health South Florida
Malaghan Institute of Medical Research
Allogene Therapeutics
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Gilead Sciences
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
French Innovative Leukemia Organisation
Gilead Sciences
Celgene
Thomas Jefferson University
Northside Hospital, Inc.
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sanofi
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Affimed GmbH
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota